3 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow maxacalcitol: new trials by email Literature Review of maxacalcitol trials Research Report on maxacalcitol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism paricalcitol, maxacalcitol, paricalcitol placebo - Secondary Hyperparathyroidism, Hemodialysis | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 255 | 2011-05-01 | 2013-06-06 |
| Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism paricalcitol, maxacalcitol - Secondary Hyperparathyroidism, Hemodialysis | Phase 2 | Completed | Abbott | 47 | 2009-10-01 | 2011-07-11 |
| Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis Maxacalcitol, Paricalcitol - Chronic Kidney Disease on Hemodialysis, Secondary Hyperparathyroidism | Phase 2 | Completed | Abbott | 153 | 2008-04-01 | 2012-01-20 |
Hyperparathyroidism, Secondary (3) · Renal Insufficiency, Chronic (1)
Abbott (2) · AbbVie (prior sponsor, Abbott) (1)
Japan (3)
Kazuya Kobayashi, BA (1) · Moriaki Kubo (1) · Ryotaro Matsuzawa (1)